Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.12
-0.03-2.61%
At close: Nov 14, 4:00 PM EST
$1.12
0.00360.32%
After Hours: 7:38 PM EST
Comments
Loading...
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Geron (GERN) stock?
You can purchase shares of Geron (NASDAQ:GERN) through any online brokerage.
Who are Geron (GERN) competitors?
Other companies in Geron’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), KalVista Pharmaceuticals (NASDAQ:KALV), CytomX Therapeutics (NASDAQ:CTMX), Gyre Therapeutics (NASDAQ:GYRE) and Valneva (NASDAQ:VALN).
What is the forecast, or price target, for Geron (GERN) stock?
Geron has a consensus price target of $5.38.
What is the current price for Geron (GERN)?
The stock price for Geron (NASDAQ: GERN) is $1.1236 last updated November 14, 2025 at 7:38 PM EST.
Does Geron (GERN) pay a dividend?
There are no upcoming dividends for Geron.
When is Geron (NASDAQ:GERN) reporting earnings?
Geron’s Q3 earnings are confirmed for Wednesday, November 5, 2025.
Is Geron (GERN) going to split?
There is no upcoming split for Geron.
What sector and industry does Geron (GERN) operate in?
Geron is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
